| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Aspergillosis | D001228 | 5 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Gonorrhea | D006069 | 7 associated lipids |
| Xerostomia | D014987 | 6 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kristanc L et al. | Effects of the pore-forming agent nystatin on giant phospholipid vesicles. | 2012 | Biochim. Biophys. Acta | pmid:22178865 |
| Kaufman DA | "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants. | 2012 | Early Hum. Dev. | pmid:22633513 |
| Khan MA et al. | Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice. | 2012 | FEMS Immunol. Med. Microbiol. | pmid:22612788 |
| Martins HP et al. | Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species. | 2012 | Acta Derm. Venereol. | pmid:21918792 |
| Shanmughapriya S et al. | In vitro actinomycete biofilm development and inhibition by the polyene antibiotic, nystatin, on IUD copper surfaces. | 2012 | Biofouling | pmid:22963125 |
| Blyth CC et al. | Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. | 2012 | J Paediatr Child Health | pmid:22970680 |
| Gerstein AC et al. | Parallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast. | 2012 | Genetics | pmid:22714405 |
| Kaomongkolgit R et al. | Antifungal activity of coronarin D against Candida albicans. | 2012 | Oral Surg Oral Med Oral Pathol Oral Radiol | pmid:22727093 |
| Mima EG et al. | Comparison of Photodynamic Therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial. | 2012 | Clin. Microbiol. Infect. | pmid:22731617 |
| Fernández Campos F et al. | Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. | 2012 | J Pharm Sci | pmid:22777575 |
| Kalema N et al. | Oral antimicrobial rinse to reduce mycobacterial culture contamination among tuberculosis suspects in Uganda: a prospective study. | 2012 | PLoS ONE | pmid:22808020 |
| Baugé C et al. | Regulatory mechanism of transforming growth factor beta receptor type II degradation by interleukin-1 in primary chondrocytes. | 2012 | Biochim. Biophys. Acta | pmid:22425785 |
| Semis R et al. | Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in mice. | 2012 | J. Antimicrob. Chemother. | pmid:22499997 |
| Leibovitz E | Strategies for the prevention of neonatal candidiasis. | 2012 | Pediatr Neonatol | pmid:22503254 |
| Bhattacharya S et al. | DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. | 2012 | Nano Lett. | pmid:22375622 |
| Al-Dwairi ZN et al. | The effect of antifungal agents on surface properties of poly(methyl methacrylate) and its relation to adherence of Candida albicans. | 2012 | J Prosthodont Res | pmid:22841909 |
| Seipke RF et al. | Isolating antifungals from fungus-growing ant symbionts using a genome-guided chemistry approach. | 2012 | Meth. Enzymol. | pmid:23084933 |
| Yang Y et al. | A chloroplast envelope membrane protein containing a putative LrgB domain related to the control of bacterial death and lysis is required for chloroplast development in Arabidopsis thaliana. | 2012 | New Phytol. | pmid:21916894 |
| Hingston CD et al. | Impact of nystatin on Candida and the oral microbiome. | 2012 | Crit Care | pmid:22827886 |
| Giglio M et al. | Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial. | 2012 | Crit Care | pmid:22490643 |